Martin Shkreli (Dennis Van Tine/Sipa USA/Sipa via AP Images)

Af­ter a huge sale, 'Phar­ma Bro' Mar­tin Shkre­li’s cryp­to to­ken plum­mets

“Phar­ma Bro” Mar­tin Shkre­li seems to be hav­ing a tough time man­ag­ing his cryp­to am­bi­tions. Shkre­li has ap­par­ent­ly sold off a huge share of his own cryp­tocur­ren­cy, caus­ing its val­ue to plum­met, ac­cord­ing to re­ports by Bloomberg News.

Shkre­li had been sen­tenced to sev­en years for his role in de­fraud­ing in­vestors in two of his funds. But it was his de­ci­sion to ac­quire Dara­prim and hike the price 5,000% that trig­gered a pub­lic out­rage.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.